Hyperparathyroidism, Secondary (Disease Or Phenotype)

Omim:MTHU008799

Nci:C113335

Msh:D006962

Mondo:MONDO:6964

Medcin:MEDCIN:30464

Mdr:MDR:10020708

Id:02936970-a0d2-5895-b7cc-bc02c3f4778f

Icpc2icd10eng:MTHU036317

Efo:EFO:1001173

Doid:DOID:12466

Chv:CHV:6433

Linked to

	Label	Description
	Etelcalcetide indication Hyperparathyroidism, Secondary Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Evocalcet indication Hyperparathyroidism, Secondary Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Upacicalcet indication Hyperparathyroidism, Secondary Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Etelcalcetide indication Hyperparathyroidism, Secondary

A Knowledge Graph Assertion from IDG

Evocalcet indication Hyperparathyroidism, Secondary

A Knowledge Graph Assertion from IDG

Upacicalcet indication Hyperparathyroidism, Secondary

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.